Selected Publications
Stoller, K.B., Bigelow, G.E. Regulatory, Cost and Policy Issues. In: Strain, E.C. and Stitzer, M.L. (Eds.) Methadone Treatment for Opioid Dependence. Baltimore: The Johns Hopkins University Press, 1999.
Strain, E.C., Stoller, K.B. (1999). Introduction and Historical Overview. In: Strain, E.C. and Stitzer, M.L. (Eds.) Methadone Treatment for Opioid Dependence. Baltimore: Johns Hopkins University Press, 1-14.
Stoller, K.B., Bigelow, G.E., Walsh, S.L., Strain, E.C. Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology. 2001; 154(3):230-242.
King, V.L., Kidorf, M.S., Stoller, K.B., Carter, J.A., Brooner, R.K. Influence of antisocial personality subtypes on drug abuse treatment response. Journal of Nervous and Mental Disease 189:593-601, 2001.
King, V.L., Stoller, K.B., Hayes, M., Umbricht, A., Curran, M., Kidorf, M., Carter, J.A., Schwartz, R., Brooner, R.K. A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence 65:137-148, 2002.
Stoller, K.B., King, V.L., Clark, M.R., Brooner, R.K. Office-based buprenorphine maintenance: Setting the stage for success. Advanced Studies in Medicine. 2006; 6(3):124-134.
Stoller, K.B., Bigelow, G.E. Introduction and Historical Overview. In: Strain, E.C. and Stitzer, M.L. (Eds.) The Treatment of Opioid Dependence. Baltimore: The Johns Hopkins University Press, 2006.
Stoller, K.B., Bigelow, G.E. Regulatory, Cost and Policy Issues. In: Strain, E.C. and Stitzer, M.L. (Eds.) The Treatment of Opioid Dependence. Baltimore: The Johns Hopkins University Press, 2006.
Stoller, K.B., King, V.L., Kidorf, M.S., Neufeld, K.S., Brooner, R.K. DSM-III-R versus DSM-IV substance use disorders: Concordance in drug users homogeneous for chronic and severe problems. Addictive Disorders and Their Treatment. 2006; 5(4):165-171.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.